Method For Diagnosing Irritable Bowel Syndrome and Monitoring Inflammatory Bowel Disease
AssigneeTechlab, Inc.
InventorsJAMES HUNTER BOONE, DAVID MAXWELL LYERLY, TRACY DALE WILKINS, RICHARD LITTLETON GUERRANT
Life of this patent
Estimating the term…
Loading patent…
AssigneeTechlab, Inc.
InventorsJAMES HUNTER BOONE, DAVID MAXWELL LYERLY, TRACY DALE WILKINS, RICHARD LITTLETON GUERRANT
Estimating the term…
A method for aiding in differentiating irritable bowel syndrome from inflammatory bowel disease by determining the level of total endogenous human lactoferrin in clinical specimens, such as feces, mucus and bile, wherein an elevated level of lactoferrin substantially precludes diagnoses of IBS and other noninflammatory etiologies, and a kit usable in such method are provided. Further provided is a method for quantitating the level of total endogenous human lactoferrin in clinical specimens, such as feces, mucus and bile, to monitor gastrointestinal inflammation in persons having inflammatory bowel disease.
A method for diagnosing irritable bowel syndrome, the method comprising:
The method of claim 7, wherein if said optical density of said readable enzyme-linked antibody bound sample is greater than 0.200, said sample contains an elevated level of endogenous lactoferrin.
A method for monitoring a human having inflammatory bowel disease for gastrointestinal inflammation, the method comprising:
Dependencies are inferred from the claim text.